Is Dyne Therapeutics, Inc. overvalued?

Dyne Therapeutics, Inc. (DYN) — key valuation metrics and fundamentals.

No verdict

Price

$26.22

Fair value

—

Current P/E

—

Normal P/E

45.0

Market cap

$4.91B

Dividend yield

0.0%

Return on equity

-64.3%

Sector

Healthcare

Fair value compares DYN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks